Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • Medical Jobs
  • Medical Matrimony
  • MD Brand Connect
  • MDTV
    • Anesthesia
    • CTVS
    • Cardiology
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • Diet and nutrition
    • ENT
    • Gastroenterology
    • Health Dialogues
    • Health News today
    • Health Shorts
    • Health Updates
    • Health video of the day
    • Laboratory Medicine
    • Latest Videos
    • Latest Webinars
    • MD shorts
    • Medical News Today
    • Medical Updates
    • Medical Video of the day
    • Medicine
    • Medico Legal Update
    • Nephrology
    • Neurology and Neurosurgery
    • Obstetrics and Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics & Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Top Videos
    • Urology
Medical Dialogues
  • Medical News
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Medical Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
    • Pharmacy Education News
  • MDTV
      • Anesthesia
      • CTVS
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • Diet and nutrition
      • ENT
      • Gastroenterology
      • Health Dialogues
      • Health News today
      • Health Shorts
      • Health Updates
      • Health video of the day
      • Laboratory Medicine
      • Latest Videos
      • Latest Webinars
      • MD shorts
      • Medical News Today
      • Medical Updates
      • Medical Video of the day
      • Medicine
      • Medico Legal Update
      • Nephrology
      • Neurology and Neurosurgery
      • Obstetrics and Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics & Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Top Videos
      • Urology
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Medical Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
  • Case of the Day
  • Editorial
  • Home
  • Oncology
  • Oncology News
  • Rovalpituzumab...

Rovalpituzumab tesirine ineffective against small cell lung cancer, confirm four studies

Hina ZahidWritten by Hina Zahid Published On 2021-09-23T09:00:19+05:30  |  Updated On 2021-09-23T09:00:47+05:30
Rovalpituzumab tesirine ineffective against small cell lung cancer, confirm four studies
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Email
  • koo
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Email
  • koo
  • Facebook
  • Twitter
  • Whatsapp
  • Telegram
  • Linkedin
  • Email
  • koo

DENVER - Four independent studies published in the Journal of Thoracic Oncology (JTO) demonstrate that rovalpituzumab tesirine for small-cell lung cancer (SCLC) is not effective against SCLC, casting a pall over the future of the therapy and closing a door that seemed opened four years ago when the first study on the therapy was published. The JTO is the official journal of the...

DENVER - Four independent studies published in the Journal of Thoracic Oncology (JTO) demonstrate that rovalpituzumab tesirine for small-cell lung cancer (SCLC) is not effective against SCLC, casting a pall over the future of the therapy and closing a door that seemed opened four years ago when the first study on the therapy was published. The JTO is the official journal of the International Association for the Study of Lung Cancer.

An accompanying editorial written by Dr. Dipesh Uprety, Dr. Jordi Remon, and JTO Editor Dr. Alex A. Adjei, discusses the recent history of the therapy's clinical trials and suggests some possible reasons why the drug has not been effective.

According to the editorial, SCLC remains a difficult disease to treat, especially at the time of relapse. Currently, topotecan is among the most effective, but it is not the most desirable and favored drug in the second-line setting because of its toxicity profile. Still, it has been difficult for new agents to "beat" this drug in the second-line setting. Several phase III clinical trials have failed to reveal improved survival over topotecan.

In 2017, clinicians were cautiously optimistic when Dr. Charles Rudin and colleagues published one of the first studies on rovalpituzumab tesirine in Lancet Oncology.

"The first in-human phase 1 clinical trial with Rova-T elicited significant enthusiasm because of the efficacy results--11 Of 60 assessable patients with pretreated SCLC who received an active dose of Rova-T achieved a confirmed response for an objective response rate (ORR) of 18%, tumors with high DLL3 expression (50% expression on tumor cells), the ORR was 38%. In a post hoc analysis, the ORR did not differ between those treated in the second- or third-line setting," according to the editorial.

But the four studies published in this month's JTO demonstrates that rovalpituzumab tesirine could not displace topotecan as an effective therapy for SCLC.

In one study published in the JTO—"Efficacy and Safety of Rovalpituzumab Tesirine Compared With Topotecan as Second-Line Therapy in DLL3-High SCLC: Results From the Phase 3 TAHOE Study," lead author Dr. Fiona Blackhall, The University of Manchester, Manchester, United Kingdom, concluded that "compared with topotecan, which is the current standard second-line chemotherapy, Rova-T exhibited an inferior overall survival and higher rates of serosal effusions, photosensitivity reaction, and peripheral edema in patients with SCLC."

A second study published in JTO, "A Phase 1–2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC," the researchers, led by Dr. Jyoti Malhotra, Rutgers Cancer Institute of New Jersey, New Brunswick, N.J., found that "Despite encouraging antitumor activity in previously treated ES SCLC, combination therapy with Rova-T and nivolumab plus or minus ipilimumab was not well tolerated at the dose levels and administration schedules evaluated."

https://www.sciencedirect.com/science/article/pii/S1556086421017093

journal of thoracic oncology rovalpituzumab tesirine lung cancer 
Hina Zahid
Hina Zahid

    Hina Zahid Joined Medical Dialogue in 2017 with a passion to work as a Reporter. She coordinates with various national and international journals and association and covers all the stories related to Medical guidelines, Medical Journals, rare medical surgeries as well as all the updates in the medical field. Email: editorial@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story
    Similar Posts
    New imaging technology less accurate than MRI at detecting prostate cancer, trial shows

    New imaging technology less accurate than MRI at detecting prostate cancer, trial shows

    Sleep duration linked to increased risk of cancer and related mortality

    Sleep duration linked to increased risk of cancer and related mortality

    Chest CT not reliable for distinguishing malignant tumors from benign pulmonary anomalies in kids: JAMA

    Chest CT not reliable for distinguishing malignant tumors from benign pulmonary anomalies in kids:...

    Carbon Monoxide Foam may Help Fight Inflammation and stimulate tissue regeneration

    Carbon Monoxide Foam may Help Fight Inflammation and stimulate tissue regeneration

    Mechanism controlling spread of pancreatic cancer discovered by scientists

    Mechanism controlling spread of pancreatic cancer discovered by scientists

    Cancer drug which shows potential as treatment for muscular dystrophy

    Cancer drug which shows potential as treatment for muscular dystrophy

    Electronic noses effectively detect cancer with high accuracy using exhaled breath: JAMA

    Electronic noses effectively detect cancer with high accuracy using exhaled breath: JAMA

    Additional taxane maintenance therapy fails to  improve survival for women with advanced cancers

    Additional taxane maintenance therapy fails to improve survival for women with advanced cancers

    Western-style diet linked to incident colorectal cancer through intestinal microbiota

    Western-style diet linked to incident colorectal cancer through intestinal microbiota

    COVID-19 Vaccines for patients treated for Lung Cancer with Immune checkpoint inhibitors

    COVID-19 Vaccines for patients treated for Lung Cancer with Immune checkpoint inhibitors

    Serum lipid levels may help predict colorectal cancer: BMJ

    Serum lipid levels may help predict colorectal cancer: BMJ

    Preoperative MRI may lead to better surgical outcomes for prostate cancer patients

    Preoperative MRI may lead to better surgical outcomes for prostate cancer patients

    Machine learning  effective in predicting oral cancer risk

    Machine learning effective in predicting oral cancer risk

    Editorial

    Propranolol and essential tremors: A critical review

    Propranolol and essential tremors: A critical review

    Safeguarding Mental Health of Doctors & How They Can Prevent a Burnout

    Safeguarding Mental Health of Doctors & How They Can Prevent a Burnout

    Analyzing the Role of Levofloxacin in Urinary Tract Infections-A review

    Analyzing the Role of Levofloxacin in Urinary Tract Infections-A review

    Management of Allergic Rhinitis during COVID-19 Pandemic

    Management of Allergic Rhinitis during COVID-19 Pandemic

    Role of Probiotics in recurrent bacterial vaginosis: A review

    Role of Probiotics in recurrent bacterial vaginosis: A review

    View All

    Journal Club Today

    Spinal fractures in the elderly can be prevented with simple X-rays

    Spinal fractures in the elderly can be prevented with simple X-rays

    View All

    Health News Today

    Health Bulletin 4/July/2022

    Health Bulletin 4/July/2022

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X